Key Insights

Highlights

Success Rate

86% trial completion

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 52/100

Termination Rate

8.3%

1 terminated out of 12 trials

Success Rate

85.7%

-0.8% vs benchmark

Late-Stage Pipeline

17%

2 trials in Phase 3/4

Results Transparency

0%

0 of 6 completed with results

Key Signals

86% success

Data Visualizations

Phase Distribution

12Total
Not Applicable (8)
P 2 (2)
P 3 (1)
P 4 (1)

Trial Status

Completed6
Unknown2
Not Yet Recruiting1
Terminated1
Withdrawn1
Recruiting1

Trial Success Rate

85.7%

Benchmark: 86.5%

Based on 6 completed trials

Clinical Trials (12)

Research Network

Activity Timeline